HomeFULC • NASDAQ
add
Fulcrum Therapeutics Inc
Previous close
$3.67
Day range
$3.69 - $3.84
Year range
$2.87 - $13.70
Market cap
238.05M USD
Avg Volume
2.71M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 80.00M | 8,990.91% |
Operating expense | 10.25M | -0.74% |
Net income | 55.41M | 332.98% |
Net profit margin | 69.26 | 102.56% |
Earnings per share | 0.87 | 328.95% |
EBITDA | 52.87M | 297.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 273.78M | -1.58% |
Total assets | 294.26M | -2.02% |
Total liabilities | 20.47M | -17.82% |
Total equity | 273.79M | — |
Shares outstanding | 62.40M | — |
Price to book | 0.83 | — |
Return on assets | 49.82% | — |
Return on capital | 51.75% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 55.41M | 332.98% |
Cash from operations | 58.90M | 383.37% |
Cash from investing | -12.51M | -162.93% |
Cash from financing | 377.00K | 165.49% |
Net change in cash | 46.77M | 6,189.58% |
Free cash flow | 37.61M | 399.40% |
About
Founded
2015
Website
Employees
76